ArticleJournal of neurosurgery. Case lessons2025
MR-guided focused ultrasound thalamotomy in a patient with thrombocytopenia: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antithrombotic management in magnetic resonance-guided focused ultrasound: Should these therapies be discontinued?Surgical neurology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMR-guided focused ultrasound (MRgFUS) thalamotomy is a relatively novel technique used to treat essential tremor (ET) and tremor-dominant Parkinson's disease. It is thought to be a safer alternative to other treatments, with no reported cases of major intracranial bleeding to date. However, experience with patients at increased risk of hemorrhage is still limited. OBSERVATIONS: The authors present the case of a successfully treated ET patient with thrombocytopenia who experienced no postprocedural complications, detailing the surgical optimization strategy used. They conducted a systematic review of the literature, focusing on articles addressing MRgFUS in patients with known coagulation disorders. The Embase, Scopus, and MEDLINE databases were queried from their inception to August 20, 2024. Of the 973 screened abstracts, 2 relevant studies were identified. The first study included 40 patients undergoing MRgFUS without interruption of antiplatelet or anticoagulant therapy, while the second was a case report of a patient with von Willebrand disease. Both studies reported satisfactory safety profiles, with no increased incidence of hemorrhagic or other complications. LESSONS: Although evidence is limited due to the small number of studies and cases, these findings suggest that MRgFUS, with appropriate periprocedural optimization, represents a viable option for patients at heightened risk of intracranial hemorrhage. https://thejns.org/doi/10.3171/CASE2525.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.